Drugs / Flagellin/F1/V
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01381744 | Feb 2012 → Aug 2014 | plague | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flagellin/F1/V | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01381744 ↗ |
| Modality | Vaccine | “recombinant fusion protein vaccine” NCT01381744 ↗ |
| Route | Intramuscular | “administered by the intramuscular route” NCT01381744 ↗ |